Loading...

By Sofía Garduño - Fri, 08/08/2025 - 12:15

Knight Therapeutics submits Parkinson’s treatment CREXONT for COFEPRIS review in Mexico, following regulatory advances in Canada.

Partnership Content

https://mexicobusiness.news/tag/neurological-disorders

More Health

By MBN Staff - Mon, 07/28/2025 - 08:59

Donanemab receives EMA panel’s recommendation for treating early Alzheimer’s, with implications for healthcare systems across the world.

By MBN Staff - Mon, 07/21/2025 - 17:12

The GPCR targeting market is set to grow to US$6.1 billion by 2029, driven by chronic diseases and advances in drug discovery technologies.

By MBN Staff - Tue, 05/27/2025 - 09:35

The neurology market is set to grow to US$94.8 billion by 2029, driven by aging populations and rising neurological disorders globally.

By Sofía Garduño - Fri, 05/23/2025 - 17:11

The digital therapeutics market is expected to hit US$19.76 billion by 2035, driven by tech innovation and rising demand for patient-centered care.

By MBN Staff - Thu, 05/15/2025 - 18:31

A new study by P&G Health finds that 83% of people with peripheral neuropathy in Mexico are undiagnosed, despite major life disruptions.